Thailand's home-grown Covid-19 vaccine to start production first quarter 2022


Image from The Nation Thailand/ANN

BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.

Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Thailand , Covid-19 , Vaccine , ChulaCov19 , mRNA

   

Next In Aseanplus News

Holes poked in Mt Fuji view barrier, Japanese town says
River rangers stem flow of plastic
Kim’s plans up in smoke
Indians demand more jobs at home
Shanghai lifts home-buying curbs to boost property sector
Flashy online stars get the boot
34 still in hospital a week after Singapore Airlines’ turbulence
Strengthening ties, emergency response on PMs’ agenda
Tropical storm leaves at least seven dead
Protesters rally as opposition pushes contentious reform Bill

Others Also Read